NO992206L - Nye reagenser og en metode for lyse av erytrocytter - Google Patents

Nye reagenser og en metode for lyse av erytrocytter

Info

Publication number
NO992206L
NO992206L NO992206A NO992206A NO992206L NO 992206 L NO992206 L NO 992206L NO 992206 A NO992206 A NO 992206A NO 992206 A NO992206 A NO 992206A NO 992206 L NO992206 L NO 992206L
Authority
NO
Norway
Prior art keywords
erythrocytes
lysis
new reagents
nitrogen containing
containing heterocycle
Prior art date
Application number
NO992206A
Other languages
English (en)
Norwegian (no)
Other versions
NO992206D0 (no
Inventor
Andre Van Agthoven
David Jarrossay
Original Assignee
Immunotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Sa filed Critical Immunotech Sa
Publication of NO992206D0 publication Critical patent/NO992206D0/no
Publication of NO992206L publication Critical patent/NO992206L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO992206A 1998-05-07 1999-05-06 Nye reagenser og en metode for lyse av erytrocytter NO992206L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806055A FR2778413B1 (fr) 1998-05-07 1998-05-07 Nouveaux reactifs et methode de lyse des erythrocytes

Publications (2)

Publication Number Publication Date
NO992206D0 NO992206D0 (no) 1999-05-06
NO992206L true NO992206L (no) 1999-11-08

Family

ID=9526319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992206A NO992206L (no) 1998-05-07 1999-05-06 Nye reagenser og en metode for lyse av erytrocytter

Country Status (11)

Country Link
US (1) US6143567A (de)
EP (1) EP0955543B1 (de)
JP (2) JPH11352125A (de)
AT (1) ATE237806T1 (de)
AU (1) AU747910B2 (de)
DE (2) DE955543T1 (de)
ES (1) ES2141073T1 (de)
FR (1) FR2778413B1 (de)
GR (1) GR990300041T1 (de)
NO (1) NO992206L (de)
NZ (1) NZ335594A (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
US7465584B2 (en) * 2005-01-24 2008-12-16 Sysmex Corporation Method and reagent for classifying leukocytes in animal blood
DK3035798T3 (en) * 2013-08-20 2018-11-19 Univ Yeditepe CELL CRYO-CONSERVATION MEDIUM ADDED TO DRILL
EP3151866B1 (de) 2014-06-09 2023-03-08 Voyager Therapeutics, Inc. Chimäre kapside
RU2716991C2 (ru) 2014-11-05 2020-03-17 Вояджер Терапьютикс, Инк. Полинуклеотиды aadc для лечения болезни паркинсона
KR20230145206A (ko) 2014-11-14 2023-10-17 보이저 테라퓨틱스, 인크. 조절성 폴리뉴클레오티드
WO2016077687A1 (en) 2014-11-14 2016-05-19 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (als)
US11697825B2 (en) 2014-12-12 2023-07-11 Voyager Therapeutics, Inc. Compositions and methods for the production of scAAV
WO2017075335A1 (en) 2015-10-28 2017-05-04 Voyager Therapeutics, Inc. Regulatable expression using adeno-associated virus (aav)
US10215683B2 (en) 2015-11-02 2019-02-26 Chiranjit Deka Light scatter based apparatus and methods for hematology analysis using only three detectors
EP3448874A4 (de) 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. Zusammensetzungen zur behandlung einer erkrankung
US11299751B2 (en) 2016-04-29 2022-04-12 Voyager Therapeutics, Inc. Compositions for the treatment of disease
KR102427379B1 (ko) 2016-05-18 2022-08-02 보이저 테라퓨틱스, 인크. 헌팅톤 질환을 치료하기 위한 조성물 및 방법
KR20240056729A (ko) 2016-05-18 2024-04-30 보이저 테라퓨틱스, 인크. 조절성 폴리뉴클레오티드
WO2018044933A1 (en) 2016-08-30 2018-03-08 The Regents Of The University Of California Methods for biomedical targeting and delivery and devices and systems for practicing the same
WO2018048586A1 (en) * 2016-09-06 2018-03-15 Chiranjit Deka Improved reagent and method for identification and enumeration of basophils
JP2020518258A (ja) 2017-05-05 2020-06-25 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. 筋萎縮性側索硬化症(als)治療組成物および方法
JP2020518259A (ja) 2017-05-05 2020-06-25 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. ハンチントン病治療組成物および方法
WO2018220835A1 (ja) * 2017-06-02 2018-12-06 日立化成株式会社 血液試料中の希少細胞を分離する方法及び該細胞の遺伝子を解析する方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CA3070087A1 (en) 2017-07-17 2019-01-24 Voyager Therapeutics, Inc. Trajectory array guide system
EP3808849A1 (de) 2017-08-03 2021-04-21 Voyager Therapeutics, Inc. Zusammensetzungen und verfahren zur aav-freisetzung
BR102018015288A2 (pt) 2017-08-08 2021-11-09 Euroimmun Medizinische Labordiagnostika Ag Método para comprovar uma ativação de basófilos
EP3441763A1 (de) 2017-08-08 2019-02-13 Euroimmun Medizinische Labordiagnostika AG Verfahren zum nachweis einer basophilenaktivierung
AU2018338728B2 (en) 2017-09-29 2025-01-02 Centre National De La Recherche Scientifique (Cnrs) Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery
EP3697908A1 (de) 2017-10-16 2020-08-26 Voyager Therapeutics, Inc. Behandlung von amyotropher lateralsklerose (als)
TW202413649A (zh) 2017-10-16 2024-04-01 美商航海家醫療公司 肌萎縮性脊髓側索硬化症(als)之治療
EP3762500A1 (de) 2018-03-06 2021-01-13 Voyager Therapeutics, Inc. Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
KR20210019996A (ko) 2018-05-15 2021-02-23 보이저 테라퓨틱스, 인크. 파킨슨병의 치료를 위한 조성물 및 방법
US20210207167A1 (en) 2018-05-16 2021-07-08 Voyager Therapeutics, Inc. Aav serotypes for brain specific payload delivery
US20210214749A1 (en) 2018-05-16 2021-07-15 Voyager Therapeutics, Inc. Directed evolution
US20210254103A1 (en) 2018-07-02 2021-08-19 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
CN112770812A (zh) 2018-07-24 2021-05-07 沃雅戈治疗公司 产生基因治疗制剂的系统和方法
EP3856762A1 (de) 2018-09-28 2021-08-04 Voyager Therapeutics, Inc. Frataxin-expressionskonstrukte mit gentechnisch veränderten promotoren und verfahren zu deren verwendung
WO2020072849A1 (en) 2018-10-04 2020-04-09 Voyager Therapeutics, Inc. Methods for measuring the titer and potency of viral vector particles
SG11202107645RA (en) 2019-01-18 2021-08-30 Voyager Therapeutics Inc Methods and systems for producing aav particles
EP3962536A1 (de) 2019-04-29 2022-03-09 Voyager Therapeutics, Inc. Systeme und verfahren zur herstellung von baculovirusinfizierten insektenzellen (biics) in bioreaktoren
EP4010465A1 (de) 2019-08-09 2022-06-15 Voyager Therapeutics, Inc. Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
EP4022070A1 (de) 2019-08-26 2022-07-06 Voyager Therapeutics, Inc. Kontrollierte expression viraler proteine
CN111504887B (zh) * 2020-05-09 2023-05-09 苏州四正柏生物科技有限公司 一种溶血素及其制备方法
WO2022032153A1 (en) 2020-08-06 2022-02-10 Voyager Therapeutics, Inc. Cell culture medium for use in producing gene therapy products in bioreactors
WO2022187548A1 (en) 2021-03-03 2022-09-09 Voyager Therapeutics, Inc. Controlled expression of viral proteins
WO2022187473A2 (en) 2021-03-03 2022-09-09 Voyager Therapeutics, Inc. Controlled expression of viral proteins
US20260085328A1 (en) 2022-09-08 2026-03-26 Voyager Therapeutics, Inc. Controlled expression of viral proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884579A (en) * 1973-06-14 1975-05-20 Cambridge Chemical Products In Method for counting blood platelets
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4637986A (en) * 1983-08-22 1987-01-20 Ortho Diagnostic Systems, Inc. Flow cytometry lysing reagent with leukoprotective agent for producing a 3-part WBC count
US4902613A (en) * 1984-05-14 1990-02-20 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
US5188935A (en) * 1984-05-31 1993-02-23 Coulter Electronics, Inc. Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
JP2836865B2 (ja) * 1989-10-23 1998-12-14 東亜医用電子株式会社 血液中の白血球およびヘモグロビンの測定用試薬
US5316951A (en) * 1991-06-07 1994-05-31 Carver Jr Edward L Method for the improved determination of white blood cell subpopulations
JP3177863B2 (ja) * 1992-07-17 2001-06-18 東ソー株式会社 不安定型糖化ヘモグロビンの除去方法
EP0685994B1 (de) * 1993-02-25 2007-03-21 Abbott Laboratories Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
FR2705359B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine.
FR2705360B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire.
JPH08189924A (ja) * 1994-03-07 1996-07-23 Sekisui Chem Co Ltd 安定型糖化ヘモグロビンの測定方法
JP3324050B2 (ja) * 1994-10-31 2002-09-17 日本光電工業株式会社 白血球分類用試薬および白血球分類方法
US5763280A (en) * 1997-01-21 1998-06-09 Coulter International Corp. Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
JP3830613B2 (ja) * 1997-04-18 2006-10-04 シスメックス株式会社 血液中の白血球及びヘモグロビン濃度測定試薬
RU2216549C2 (ru) * 1997-11-07 2003-11-20 Дайити Фармасьютикал Ко., Лтд. Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс

Also Published As

Publication number Publication date
AU2698499A (en) 2000-04-13
EP0955543A1 (de) 1999-11-10
US6143567A (en) 2000-11-07
JPH11352125A (ja) 1999-12-24
JP2008224696A (ja) 2008-09-25
ES2141073T1 (es) 2000-03-16
JP4446059B2 (ja) 2010-04-07
GR990300041T1 (en) 2000-01-31
DE955543T1 (de) 2000-06-08
EP0955543B1 (de) 2003-04-16
FR2778413B1 (fr) 2000-08-04
DE69906859T2 (de) 2004-01-29
NO992206D0 (no) 1999-05-06
DE69906859D1 (de) 2003-05-22
NZ335594A (en) 2000-02-28
AU747910B2 (en) 2002-05-30
FR2778413A1 (fr) 1999-11-12
ATE237806T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
NO992206D0 (no) Nye reagenser og en metode for lyse av erytrocytter
DE3584902D1 (de) Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
IL103056A (en) Method for sphering of red blood cells
ES2043762T3 (es) Reactivos desnaturalizantes para la determinacion conveniente de derivados de hemoglobina en sangre.
PL334793A1 (en) Reagent for measuring haemoglobin content and determining leukocytes in a blood sample
ES2185015T3 (es) Fluido para la recogida de muestras.
DE3751109D1 (de) Reagenzien zur Bestimmung von Peptidoglykan und beta-1,3-Glukan.
KR960007789A (ko) 단백질 c/단백질 s시스템의 장해를 검출하기 위한 방법
ATE464562T1 (de) Lysereagens zur gleichzeitigen auszählung unterschiedlicher arten von blutzellen in einer blutprobe
ES516496A0 (es) "procedimiento para la determinacion de hemoglobina glucosilada".
DE3784528D1 (de) Zusammensetzung und verfahren zur stabilisierung von dinukleotiden.
DE69029291D1 (de) Verwendung von Lithiumsalzen zur Lysis von Erythrozyten und zur Denaturierung von Hämoglobin
DK56386A (da) Reagens til ved haemagglunitation at bestemme antistoffer mod bakterielle toksiner, fremgangsmaade til fremstilling af reagenset og dettes anvendelse
PT83826B (pt) Processo para a preparacao dum reagente para a determinacao da actividade de peroxidase
AU611438B2 (en) A method and reagent for determining ld-1 isoenzyme
EP0458594A3 (en) Analysis of hair
BR8600888A (pt) Dispersao de silica redispersivel e processo para sua preparacao
DK0625707T3 (da) Fremgangsmåde og præparat til lyse af erytrocytter, blodpræparat og fremgangsmåde til leukocytanalyse
DE3685922D1 (de) Verfahren und reagenz zur beseitigung der stoerung der analyt-wiederfindung in plasmaproben.
GB1245742A (en) Improvements in or relating to treatment of biological material
EP0248144A3 (en) Selective immunoassay for pro-urokinase and urokinase
DE60024923D1 (de) Verfahren zur Analyse der funktionellen Aktivierung von Leukocyten, Plättchen und anderen Zellen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application